Syndax Pharmaceuticals Inc

-

Assets, Funds, Holdings

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Syndax Pharmaceuticals Inc
CIK #0001395937
EDGAR Form CIK 2011 - 2025
10-K [0001395937]
10-Q [0001395937]
3 [0001395937]
4 [0001395937]
8-K [0001395937]
D [0001395937]
SC 13D [0001395937]
SC 13G [0001395937]
Form 13D/13G Filer Form 13D/13G Subject Filed
Point72 Asset Management LP Syndax Pharmaceuticals Inc [2025-08-18]
Goldman Sachs Group Inc Syndax Pharmaceuticals Inc [2025-02-12]
Morgan Stanley Syndax Pharmaceuticals Inc [2025-02-05]
Point72 Asset Management LP Syndax Pharmaceuticals Inc [2025-01-22]
Kynam Capital Management LP Syndax Pharmaceuticals Inc [2024-02-14]
Vanguard Group Inc Syndax Pharmaceuticals Inc [2024-02-13]
Point72 Asset Management LP Syndax Pharmaceuticals Inc [2023-10-31]
Wellington Management Group LLP Syndax Pharmaceuticals Inc [2023-01-10]
Nantahala Capital Management LLC Syndax Pharmaceuticals Inc [2022-02-14]
Frazier Life Sciences Public Fund LP Syndax Pharmaceuticals Inc [2021-12-23]
View All
Form 3/4/5 Subject 2011 - 2025
Podlesak Dennis
Syndax Pharmaceuticals Inc
Goldan Keith A.
Metzger Michael A
Huber Martin H. Jr.
Botwood Nicholas A.J.
Katkin Keith
Gallagher Neil
Meury William
Rizo Aleksandra
View All
Terms | Privacy | Guide
tony@aum13f.com